BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 11607811)

  • 1. Mechanisms of chromosomal translocations in B cell lymphomas.
    Küppers R; Dalla-Favera R
    Oncogene; 2001 Sep; 20(40):5580-94. PubMed ID: 11607811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of AID in tumorigenesis.
    Okazaki IM; Kotani A; Honjo T
    Adv Immunol; 2007; 94():245-73. PubMed ID: 17560277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures.
    Marculescu R; Vanura K; Montpellier B; Roulland S; Le T; Navarro JM; Jäger U; McBlane F; Nadel B
    DNA Repair (Amst); 2006 Sep; 5(9-10):1246-58. PubMed ID: 16798110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic hypermutation and B-cell lymphoma.
    Dunn-Walters D; Thiede C; Alpen B; Spencer J
    Philos Trans R Soc Lond B Biol Sci; 2001 Jan; 356(1405):73-82. PubMed ID: 11205334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic pathway to recurrent chromosome translocations in murine lymphoma involves V(D)J recombinase.
    Vanasse GJ; Halbrook J; Thomas S; Burgess A; Hoekstra MF; Disteche CM; Willerford DM
    J Clin Invest; 1999 Jun; 103(12):1669-75. PubMed ID: 10377173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for secondary V(D)J recombination in oncogenic chromosomal translocations?
    Davila M; Foster S; Kelsoe G; Yang K
    Adv Cancer Res; 2001; 81():61-92. PubMed ID: 11430596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of activation-induced deaminase in antibody diversification and chromosome translocations.
    Ramiro A; Reina San-Martin B; McBride K; Jankovic M; Barreto V; Nussenzweig A; Nussenzweig MC
    Adv Immunol; 2007; 94():75-107. PubMed ID: 17560272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism and control of V(D)J recombination versus class switch recombination: similarities and differences.
    Dudley DD; Chaudhuri J; Bassing CH; Alt FW
    Adv Immunol; 2005; 86():43-112. PubMed ID: 15705419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic events triggered by AID, the adverse effect of antibody diversification.
    Pérez-Durán P; de Yebenes VG; Ramiro AR
    Carcinogenesis; 2007 Dec; 28(12):2427-33. PubMed ID: 17804422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Origin and pathogenesis of B cell lymphomas.
    Seifert M; Scholtysik R; Küppers R
    Methods Mol Biol; 2013; 971():1-25. PubMed ID: 23296955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas.
    Pasqualucci L; Neumeister P; Goossens T; Nanjangud G; Chaganti RS; Küppers R; Dalla-Favera R
    Nature; 2001 Jul; 412(6844):341-6. PubMed ID: 11460166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome translocations in multiple myeloma.
    Bergsagel PL; Kuehl WM
    Oncogene; 2001 Sep; 20(40):5611-22. PubMed ID: 11607813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CARMA1 and chromosomal translocations in extranodal marginal zone B-cell lymphomas of MALT type or diffuse large B-cell lymphomas.
    Adam P; Haralambieva E; Greiner A; Ott M; Rosenwald A; Ott G
    Haematologica; 2006 Nov; 91(11):1575-6. PubMed ID: 17043017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
    Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
    Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of B-cell lymphoma pathogenesis.
    Küppers R
    Nat Rev Cancer; 2005 Apr; 5(4):251-62. PubMed ID: 15803153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinguishing primary and secondary translocations in multiple myeloma.
    Gabrea A; Leif Bergsagel P; Michael Kuehl W
    DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathology of lymphomas.
    Cotter FE
    Cancer Surv; 1993; 16():157-74. PubMed ID: 8348535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telomere length and correlation with histopathogenesis in B-cell leukemias/lymphomas.
    Walsh SH; Grabowski P; Berglund M; Thunberg U; Thorsélius M; Tobin G; Aleskog A; Karlsson K; Sundström C; Laurell A; Enblad G; Rosenquist R; Roos G
    Eur J Haematol; 2007 Apr; 78(4):283-9. PubMed ID: 17286609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia.
    Vanura K; Vrsalovic MM; Le T; Marculescu R; Kusec R; Jäger U; Nadel B
    Genes Chromosomes Cancer; 2009 Aug; 48(8):725-36. PubMed ID: 19455608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FAS death domain deletions and cellular FADD-like interleukin 1beta converting enzyme inhibitory protein (long) overexpression: alternative mechanisms for deregulating the extrinsic apoptotic pathway in diffuse large B-cell lymphoma subtypes.
    Takahashi H; Feuerhake F; Kutok JL; Monti S; Dal Cin P; Neuberg D; Aster JC; Shipp MA
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3265-71. PubMed ID: 16740746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.